Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: An in vivo serial pinhole gated SPECT-CT study in rats

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Garikipati, Venkata Naga Srikanth ^a   Jadhav, Sachin ^a   Pal, Lily ^a   Prakash, Prem ^b   Dikshit, Madhu ^b   Nityanand, Soniya ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; SCATTER FACTOR; SOMATOMEDIN C; TECHNETIUM 99M; TROPONIN T; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL TRACKING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENGRAFTMENT; FETUS HEART; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; CARDIAC GATED IMAGING; CELL CULTURE; CYTOLOGY; HEART VENTRICLE; HEART VENTRICLE FUNCTION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; RADIOGRAPHY; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CELL DIFFERENTIATION; CELLS, CULTURED; FETAL HEART; HEART VENTRICLES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR FUNCTION;

EID: 84903397619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100982     Document Type: Article

References (36)

1. Tang XL, Rokosh DG, Guo Y, Bolli R (2010) Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction. Circ J 74: 390-404.
2. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491-492. (Pubitemid 36173717)
3. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, et al. (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96: 127-137. (Pubitemid 40095762)
4. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, et al. (2008) Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 103: 69-77. (Pubitemid 50002796)
5. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, et al. (2008) Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103: 107-116.
6. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, et al. (2006) Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294. (Pubitemid 43739450)
7. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, et al. (2008) Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807-1818.
8. Eisen HJ (2008) Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy. Nat Clin Pract Cardiovasc Med 5: 520-521.
9. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156. (Pubitemid 40139725)
10. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, et al. (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54: 2277-2286.
11. Chen PM, Yen ML, Liu KJ, Sytwu HK, Yen BL (2011) Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci 18: 49.
12. Ramkisoensing AA, Pijnappels DA, Askar SF, Passier R, Swildens J, et al. (2011) Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PLoS One 6: e24164.
13. Pelekanos RA, Li J, Gongora M, Chandrakanthan V, Scown J, et al. (2012) Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res 8: 58-73.
14. Srikanth GV, Tripathy NK, Nityanand S (2013) Fetal cardiac mesenchymal stem cells express embryonal markers and exhibit differentiation into cells of all three germ layers. World J Stem Cells 5: 26-33.
15. Beeres SL, Bengel FM, Bartunek J, Atsma DE, Hill JM, et al. (2007) Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 49: 1137-1148. (Pubitemid 46400333)
16. Morrison AR, Sinusas AJ (2009) New molecular imaging targets to characterize myocardial biology. Cardiol Clin 27: 329-344, Table of Contents.
17. Wu JC, Abraham MR, Kraitchman DL (2010) Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 51 Suppl 1: 128S-136S.
18. Tsui BM, Kraitchman DL (2009) Recent advances in small-animal cardiovascular imaging. J Nucl Med 50: 667-670.
19. Garikipati Venkata Naga Srikanth PP, Naresh Kumar Tripathy, Madhu Dikshit, Soniya Nityanand (2009) Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of stem cell therapy Journal of stem cells and regenerative medicine 5: 30-36.
20. Tran N, Li Y, Maskali F, Antunes L, Maureira P, et al. (2006) Short-term heart retention and distribution of intramyocardial delivered mesenchymal cells within necrotic or intact myocardium. Cell Transplant 15: 351-358. (Pubitemid 44162647)
21. Dussault AA, Pouliot M (2006) Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 8: 1-10.
22. Garikipati Venkata Naga Srikanth NKT, Soniya Nityanand (2012) Isolation and characterization of cardiac mesenchymal stem cells from rat foetal hearts. International Journal of Regenerative Medicine 1: 1-8.
23. Krishnamurthy P, Thal M, Verma S, Hoxha E, Lambers E, et al. (2011) Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 109: 1280-1289.
24. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, et al. (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290: H2196-2203. (Pubitemid 43846045)
25. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, et al. (2008) Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294: H2002-2011.
26. Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, et al. (2008) Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 103: 525-536.
27. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, et al. (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 102: 3766-3771. (Pubitemid 40354686)
28. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, et al. (2012) Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med 1: 116-124.
29. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, et al. (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127: 213-223.
30. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, et al. (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868. (Pubitemid 37022130)
31. Huikuri HV, Kervinen K, Niemela M, Ylitalo K, Saily M, et al. (2008) Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 29: 2723-2732.
32. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, et al. (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115: 326-338. (Pubitemid 40385474)
33. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, et al. (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354: 700-706. (Pubitemid 46186241)
34. Christoforou N, Oskouei BN, Esteso P, Hill CM, Zimmet JM, et al. (2010) Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One 5: e11536.
35. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, et al. (2009) Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 27: 2734-2743.
36. Fehlberg S, Gregel CM, Goke A, Goke R (2003) Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO. Br J Pharmacol 139: 495-500. (Pubitemid 36819619)